APA (7th ed.) Citation

T, H., B, N., S, H., E, B., JT, K., AB, S., . . . H, S. (2021). Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Molecular oncology, 15(4), 957. https://doi.org/10.1002/1878-0261.12865

Chicago Style (17th ed.) Citation

T, Helland, et al. "Low Z-4OHtam Concentrations Are Associated with Adverse Clinical Outcome Among Early Stage Premenopausal Breast Cancer Patients Treated with Adjuvant Tamoxifen." Molecular Oncology 15, no. 4 (2021): 957. https://doi.org/10.1002/1878-0261.12865.

MLA (9th ed.) Citation

T, Helland, et al. "Low Z-4OHtam Concentrations Are Associated with Adverse Clinical Outcome Among Early Stage Premenopausal Breast Cancer Patients Treated with Adjuvant Tamoxifen." Molecular Oncology, vol. 15, no. 4, 2021, p. 957, https://doi.org/10.1002/1878-0261.12865.